Cellyan Biotechnology Granted Nasdaq Compliance Extension; Shares Rise
Cellyan Biotechnology (HKPD) has been granted an additional 180 days by Nasdaq to regain compliance with the minimum $1 bid price requirement, extending until January 11, 2027. The company's shares surged approximately 21% in post-market trading following the announcement.
Tickers: $HKPD
Topics: Nasdaq requirements stock compliance